Denmark· DK-28105566415
Praxbind
A idarucizumab product containing idarucizumab, registered in Denmark by Boehringer Ingelheim Int. GmbH. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Idarucizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC V03AB37 (idarucizumab), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Idarucizumab · ATC V03AB37
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Idarucizumab
- Manufacturer
- Boehringer Ingelheim Int. GmbH
- Country
- Denmark (DK)
- ATC code
- V03AB37
- ATC class
- Idarucizumab
- Defined daily dose
- 5 g, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105566415
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V03AB37
Idarucizumab, as other registers publish it.
- IcelandPraxbindBoehringer Ingelheim International GmbH*
- NorwayPraxbindBoehringer Ingelheim International GmbH
- PolandPraxbindBoehringer Ingelheim International GmbH
- United StatesPraxbindBoehringer Ingelheim Pharmaceuticals, Inc.
- FinlandPraxbindBoehringer Ingelheim International GmbH
- CzechiaPRAXBINDBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- CanadaPRAXBINDBOEHRINGER INGELHEIM (CANADA) LTD LTEE
- NetherlandsPraxbind 2,5 g/50 ml oplossing voor injectie/infusieBoehringer Ingelheim International GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de0e5758-ba88-4281-b1c5-6bfeef0b442f GET /v1/drugs/de0e5758-ba88-4281-b1c5-6bfeef0b442f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektions-/infusionsvæske, opløsning",
"source": "dkma",
"strength": "2,5 g/ 50 ml",
"auth_role": "CO-RAP",
"dk_drugid": "28105566415",
"substance": "Idarucizumab",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "42328"
}See everything about idarucizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.